Media

ABC7 Eyewitness News interview Dr. Timothy Chang, UCLA neurologist
In an interview with ABC7 Eyewitness News, UCLA neurologist Dr. Timothy Chang explains how a new AI tool is transforming the early detection of Alzheimer’s disease. Image courtesy of ABC7.

UCLA’s New AI Tool May Help Identify People at Risk of Undiagnosed Alzheimer’s

Dr. Timothy Chang, UCLA neurologist, explained how early diagnosis is critical for patient care and access to new therapies and that AI could help identify..

1 min read
AI generated neurons and amyloid-plaques.

UCLA Develops New Alzheimer's Disease Therapeutic

Dr. Varghese John, Dr. Istvan Mody, and colleagues were highlighted in a UCLA article about their recent therapeutic development, targeting ...

1 min read
Mirella Diaz-Santos, female, standing next to a desk smiling at the camera.

A More Inclusive Framework for Alzheimer’s Disease

The Easton Center, ELHA Lab, UCLA Neurology, Alzheimer's Los Angeles, and community leaders are working together bridging the gap between health disparities ...

1 min read
diversity group of male and female, stack hands in the center supporting active lifestyle

Healthy Body. Healthy Mind.

In the Summer Edition of Keiro Connect, Dr. Kevin Bickart discussed physical activity, including dancing, to improve brain health and prevent dementia ...

1 min read
male in studio looking back smiling.

An In-Depth Interview on Various Neurodegenerative Diseases

Dr. Keith Vossel was interviewed by Dr. Marc Siegel from Doctor Radio/Sirius XM about a wide spectrum of neurodegenerative diseases, including ...

1 min read
sundown with sparkling water by the beach

Sundowning Occurs in Patients with Alzheimer’s and Dementia

Dr. Keith Vossel was interviewed in a Forbes Health article about sundowning and the symptoms that patients with Alzheimer’s and dementia may experience ...

1 min read
diversity group of male and female, stack hands in the center supporting active lifestyle

Late Life with Active Lifestyle Lowers the Risk of Dementia

Dr. Keith Vossel was quoted in a Healthline article about a study revealed a socially and mentally active lifestyle in late life ...

1 min read
doctor_workplace with a stethoscope and a pair of glasses on top paper and a keyboard

New Released Information About the Additional Medicare Coverages for Leqembi

Dr. Keith Vossel was quoted in a Boston Globe’s STAT News article about physicians and patients showing interest in learning about the new Alzheimer’s drug...

1 min read
stethoscope and table on white background

Future Data Will Determine the Effectiveness of the New Alzheimer’s Drug

Dr. Keith Vossel was quoted in a San Francisco Chronicle article about Lecanemab.......

1 min read
Dr. Keith Vossel, male, online interview with Fox News.

Lecanemab, the New FDA-approved Alzheimer’s Drug – What to Know

Watch Dr. Keith Vossel’s live interview with Marla Tellez on July 7th, FOX 11 News LA about Lecanemab.......

1 min read
a male being interviewed virtually by a female host.

Lecanemab, the New FDA-approved Drug for Patients with Early Alzheimer’s Disease (Segment 2 of 2)

Watch Dr. Keith Vossel’s exclusive live interview with KCAL-LA Morning News, about the benefits of the treatment, possible side effects, and expected costs...

1 min read
a male being interviewed virtually by a female host.

Lecanemab, the New FDA-approved Drug for Patients with Early Alzheimer’s Disease (Segment 1 of 2)

Watch Dr. Keith Vossel’s exclusive live interview with KCAL-LA Evening News, about the benefits of the treatment, possible side effects, and expected costs...

1 min read
US Department of Health and Human Services - Food and Drug Administration (FDA) sign in front of the headquarters building

What Families Can Expect with the New FDA-Approved Alzheimer’s Medication, Leqembi

Watch Dr. Keith Vossel’s exclusive live interview with KNBC-LA, NBC Channel 4 News, about the FDA’s fully approved Alzheimer’s drug, Lecanemab....

1 min read
US Food and Drug magnified with medication in the background.

What’s Next for Leqembi After A Full Approval by the FDA

Listen to Dr. Keith Vossel’s exclusive interview with KNX News Radio, about the FDA’s full approval of the first-in-class Alzheimer’s drug, Lecanemab....

1 min read
cartoon image of cocktails

Heavy Alcohol Intake May Worsen Cognitive Decline in Alzheimer’s Disease

Dr. Keith Vossel, Director of the Easton Center, commented on recent Alzheimer’s model research suggested long-term excessive intake of alcohol can...

1 min read